143 related articles for article (PubMed ID: 33544809)
1. Primary prostate cancer synchronous with renal cell carcinoma: clinical experience and literature review.
Li ZY; Ying CC; Wan ZH; Wang ZS; Li GH; Chen L; Guo YL
Rom J Morphol Embryol; 2020; 61(2):555-561. PubMed ID: 33544809
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma.
Williamson SR; Halat S; Eble JN; Grignon DJ; Lopez-Beltran A; Montironi R; Tan PH; Wang M; Zhang S; Maclennan GT; Baldridge LA; Cheng L
Am J Surg Pathol; 2012 Oct; 36(10):1425-33. PubMed ID: 22982885
[TBL] [Abstract][Full Text] [Related]
4. [A case of prostate cancer with cyst formation].
Kim SC; Fujimoto K; Matsumoto Y; Cho M; Natsume O; Uemura H; Ozono S; Hirao Y
Hinyokika Kiyo; 2001 Sep; 47(9):653-6. PubMed ID: 11692605
[TBL] [Abstract][Full Text] [Related]
5. Renal-type clear cell carcinoma of prostate: A case report and review of literature.
Liao G; Zhang X; Li Z; Lan S; Huang M; Huang W
Indian J Pathol Microbiol; 2018; 61(3):431-433. PubMed ID: 30004074
[TBL] [Abstract][Full Text] [Related]
6. Renal-type clear cell carcinoma of the prostate: a diagnostic challenge.
Patne SC; Johri N; Katiyar R; Trivedi S; Dwivedi US
Diagn Pathol; 2015 Oct; 10():193. PubMed ID: 26498435
[TBL] [Abstract][Full Text] [Related]
7. Synchronous Type 1 Papillary Renal Cell Carcinoma in a Patient with Rectal Adenocarcinoma.
Piao J; Friedman P; Siddiqui S; Veerapong J; Lai JP
Anticancer Res; 2016 Sep; 36(9):4821-4. PubMed ID: 27630335
[TBL] [Abstract][Full Text] [Related]
8. [Synchronous triple urogenital cancer (renal cancer, bladder cancer, prostatic cancer): a case report].
Takada T; Honda M; Momohara C; Komori K; Fujioka H
Hinyokika Kiyo; 2002 Apr; 48(4):239-42. PubMed ID: 12048939
[TBL] [Abstract][Full Text] [Related]
9.
von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
[TBL] [Abstract][Full Text] [Related]
10. Synchronous primary triple neoplasia (renal cell carcinoma and prostate cancer in combination with thyroid neoplasm). Report of an unusual case.
Rai RS; Deb P; Rai R; Gupta E; Panayach JS
Minerva Urol Nefrol; 2007 Dec; 59(4):451-4. PubMed ID: 17947962
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
12. Concurrent renal cell carcinoma and urothelial carcinoma: long-term follow-up study of 27 cases.
Qi N; Chen Y; Gong K; Li H
World J Surg Oncol; 2018 Jan; 16(1):16. PubMed ID: 29370814
[TBL] [Abstract][Full Text] [Related]
13. Uncommon Localization of Extrarenal Xp11.2 Translocation-associated Renal Cell Carcinoma (RCC): Case Report.
Al-Maghrabi JA; Khabaz MN
Appl Immunohistochem Mol Morphol; 2020 Apr; 28(4):e33-e35. PubMed ID: 28877071
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
Bui MH; Seligson D; Han KR; Pantuck AJ; Dorey FJ; Huang Y; Horvath S; Leibovich BC; Chopra S; Liao SY; Stanbridge E; Lerman MI; Palotie A; Figlin RA; Belldegrun AS
Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer on computed tomography: A direct comparison with multi-parametric magnetic resonance imaging and tissue pathology.
Jia JB; Houshyar R; Verma S; Uchio E; Lall C
Eur J Radiol; 2016 Jan; 85(1):261-267. PubMed ID: 26526901
[TBL] [Abstract][Full Text] [Related]
16. Biomarker discovery in urogenital cancer.
Said J
Biomarkers; 2005 Nov; 10 Suppl 1():S83-6. PubMed ID: 16298916
[TBL] [Abstract][Full Text] [Related]
17. [Acquired cystic kidney disease-associated renal cell carcinoma: a clinicopathologic study of three cases].
Zhang W; Xu LL; Yu WJ; Wang Q; Jiang YX; Liu Y; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):366-371. PubMed ID: 29783804
[No Abstract] [Full Text] [Related]
18. Immunohistochemical distinction of renal cell carcinoma from other carcinomas with clear-cell histomorphology: utility of CD10 and CA-125 in addition to PAX-2, PAX-8, RCCma, and adipophilin.
Mentrikoski MJ; Wendroth SM; Wick MR
Appl Immunohistochem Mol Morphol; 2014 Oct; 22(9):635-41. PubMed ID: 25279712
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of ovarian cancer and renal cell carcinoma.
Huang KH; Chung SD; Huang SY; Chueh SC; Chen CA; Chen J
J Formos Med Assoc; 2007 Mar; 106(3 Suppl):S15-9. PubMed ID: 17493903
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma.
Bui MH; Visapaa H; Seligson D; Kim H; Han KR; Huang Y; Horvath S; Stanbridge EJ; Palotie A; Figlin RA; Belldegrun AS
J Urol; 2004 Jun; 171(6 Pt 1):2461-6. PubMed ID: 15126876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
